Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Mar 1;159(3):828–843. doi: 10.1084/jem.159.3.828

Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin

PMCID: PMC2187255  PMID: 6421983

Abstract

Crude preparations of interferon (IFN)-gamma derived from human peripheral blood leukocyte (PBL) cultures induced with 12-O-tetra- decanoylphorbol-13-acetate (TPA) and phytohemagglutinin (PHA) were more cytotoxic to HeLa cells than partially purified nautral or highly purified recombinant human IFN-gamma preparations. Conditioned media from PBL cultures contained, in addition to IFN-gamma, a mixture of cytotoxins, including classic lymphocyte-derived lymphotoxin (LT), and a TPA-induced cytotoxic activity produced by the adherent cell population (presumably monocytes). These two types of cytotoxins, indistinguishable in the mouse L929 cell LT assay, could be differentiated by an antiserum prepared against LT derived from the B lymphoblastoid cell line RPMI 1788. This antiserum neutralized lymphocyte-derived classic LT but failed to neutralize the activity of the monocyte-derived cytotoxin. Processing of conditioned media by sequential chromatography on silicic acid, Con A-Sepharose, and DEAE- Sephacel failed to separate IFN-gamma from the LT activity. However, this procedure did remove the monocyte-derived cytotoxic activity present in the original starting material, leaving predominantly classic LT. This LT showed a slightly basic isoelectric point (pI 7.6) which partially overlapped the more basic pI range of IFN-gamma. The two lymphokine activities also could not be completely separated by fast protein liquid chromatography or molecular sieve chromatography. LT in these partially purified preparations was associated with a protein having an apparent molecular weight of 58,000 on gel filtration. This form dissociated partially into a 20,000 mol wt species after denaturation with 0.1% NaDodSO4. IFN-gamma could be selectively removed from preparations containing both IFN-gamma and LT with the aid of monoclonal antibody to IFN-gamma. The addition of purified LT to purified E. coli-derived recombinant human IFN-gamma resulted in a marked synergistic enhancement of cytotoxicity for HeLa cells.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. O., Kao K. J., Farb R., Pizzo S. V. Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. J Immunol. 1980 Jan;124(1):293–300. [PubMed] [Google Scholar]
  2. Basham T. Y., Merigan T. C. Recombinant interferon-gamma increases HLA-DR synthesis and expression. J Immunol. 1983 Apr;130(4):1492–1494. [PubMed] [Google Scholar]
  3. Blalock J. E., Georgiades J. A., Langford M. P., Johnson H. M. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol. 1980 Feb;49(2):390–394. doi: 10.1016/0008-8749(80)90041-6. [DOI] [PubMed] [Google Scholar]
  4. Evans C. H., DiPaolo J. A. Neoplastic transformation of guinea pig fetal cells in culture induced by chemical carcinogens. Cancer Res. 1975 Apr;35(4):1035–1044. [PubMed] [Google Scholar]
  5. Farram E., Targan S. R. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing. J Immunol. 1983 Mar;130(3):1252–1256. [PubMed] [Google Scholar]
  6. Gray P. W., Leung D. W., Pennica D., Yelverton E., Najarian R., Simonsen C. C., Derynck R., Sherwood P. J., Wallace D. M., Berger S. L. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature. 1982 Feb 11;295(5849):503–508. doi: 10.1038/295503a0. [DOI] [PubMed] [Google Scholar]
  7. Klostergaard J., Long S., Granger G. A. Purification of human alpha-light class lymphotoxin to electrophoretic homogeneity. Mol Immunol. 1981 Dec;18(12):1049–1054. doi: 10.1016/0161-5890(81)90020-1. [DOI] [PubMed] [Google Scholar]
  8. Kondo L. L., Rosenau W., Wara D. W. Role of lymphotoxin in antibody-dependent cell-mediated cytotoxicity (ADCC). J Immunol. 1981 Mar;126(3):1131–1133. [PubMed] [Google Scholar]
  9. Kramer S. L., Granger G. A. The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte. Cell Immunol. 1975 Jan;15(1):57–68. doi: 10.1016/0008-8749(75)90164-1. [DOI] [PubMed] [Google Scholar]
  10. Kull F. C., Jr, Cuatrecasas P. Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum. J Immunol. 1981 Apr;126(4):1279–1283. [PubMed] [Google Scholar]
  11. Kumagai K., Itoh K., Hinuma S., Tada M. Pretreatment of plastic Petri dishes with fetal calf serum. A simple method for macrophage isolation. J Immunol Methods. 1979;29(1):17–25. doi: 10.1016/0022-1759(79)90121-2. [DOI] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Nathan C. F., Murray H. W., Wiebe M. E., Rubin B. Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983 Sep 1;158(3):670–689. doi: 10.1084/jem.158.3.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nissen-Meyer J., Hammerstrøm J. Physicochemical characterization of cytostatic factors released from human monocytes. Infect Immun. 1982 Oct;38(1):67–73. doi: 10.1128/iai.38.1.67-73.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rubin B. Y., Bartal A. H., Anderson S. L., Millet S. K., Hirshaut Y., Feit C. The anticellular and protein-inducing activities of human gamma interferon preparations are mediated by the interferon. J Immunol. 1983 Mar;130(3):1019–1020. [PubMed] [Google Scholar]
  16. Rubin B. Y., Gupta S. L. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc Natl Acad Sci U S A. 1980 Oct;77(10):5928–5932. doi: 10.1073/pnas.77.10.5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ruddle N. H., Waksman B. H. Cytotoxicity mediated by soluble antigen and lymphocytes in delayed hypersensitivity. 3. Analysis of mechanism. J Exp Med. 1968 Dec 1;128(6):1267–1279. doi: 10.1084/jem.128.6.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rundell J. O., Evans C. H. Species specificity of guinea pig and human lymphotoxin colony inhibitory activity. Immunopharmacology. 1981 Feb;3(1):9–18. doi: 10.1016/0162-3109(81)90034-5. [DOI] [PubMed] [Google Scholar]
  19. Spofford B. T., Daynes R. A., Granger G. A. Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin. J Immunol. 1974 Jun;112(6):2111–2116. [PubMed] [Google Scholar]
  20. Tyring S., Klimpel G. R., Fleischmann W. R., Jr, Baron S. Direct cytolysis by partially-purified preparations of immune interferon. Int J Cancer. 1982 Jul 15;30(1):59–64. doi: 10.1002/ijc.2910300111. [DOI] [PubMed] [Google Scholar]
  21. Walker S. M., Lee S. C., Lucas Z. J. Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes. J Immunol. 1976 Mar;116(3):807–815. [PubMed] [Google Scholar]
  22. Wallach D., Fellous M., Revel M. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature. 1982 Oct 28;299(5886):833–836. doi: 10.1038/299833a0. [DOI] [PubMed] [Google Scholar]
  23. Wallach D. Interferon-induced resistance to the killing by NK cells: a preferential effect of IFN-gamma. Cell Immunol. 1983 Feb 1;75(2):390–395. doi: 10.1016/0008-8749(83)90337-4. [DOI] [PubMed] [Google Scholar]
  24. Ware C. F., Granger G. A. Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro. J Immunol. 1981 May;126(5):1919–1926. [PubMed] [Google Scholar]
  25. Williams T. W., Bellanti J. A. In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J Immunol. 1983 Feb;130(2):518–520. [PubMed] [Google Scholar]
  26. Wright S. C., Bonavida B. Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes. J Immunol. 1981 Apr;126(4):1516–1521. [PubMed] [Google Scholar]
  27. Yamamoto R. S., Hiserodt J. C., Granger G. A. The human LT system. V. A comparison of the relative lytic effectiveness of various MW human LT classes on 51Cr-labeled allogeneic target cells in vitro: enhanced lysis by LT complexes associated with Ig-like receptor(s). Cell Immunol. 1979 Jul;45(2):261–275. doi: 10.1016/0008-8749(79)90387-3. [DOI] [PubMed] [Google Scholar]
  28. Yip Y. K., Barrowclough B. S., Urban C., Vilcek J. Molecular weight of human gamma interferon is similar to that of other human interferons. Science. 1982 Jan 22;215(4531):411–413. doi: 10.1126/science.6173921. [DOI] [PubMed] [Google Scholar]
  29. Yip Y. K., Kelker H. C., Stone-Wolff D. S., Pearlstein K., Urban C., Vilcek J. Stimulation of lymphokine production by teleocidin, aplysiatoxin, and debromoaplysiatoxin. Cell Immunol. 1983 Jul 15;79(2):389–395. doi: 10.1016/0008-8749(83)90081-3. [DOI] [PubMed] [Google Scholar]
  30. Yip Y. K., Pang R. H., Oppenheim J. D., Nachbar M. S., Henriksen D., Zerebeckyj-Eckhardt I., Vilcek J. Stimulation of human gamma interferon production by diterpene esters. Infect Immun. 1981 Oct;34(1):131–139. doi: 10.1128/iai.34.1.131-139.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yip Y. K., Pang R. H., Urban C., Vilcek J. Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1601–1605. doi: 10.1073/pnas.78.3.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES